Clinical Trials Logo

Clinical Trial Summary

This study will assess the long-term safety and tolerability of ALKS 5461 as an adjunctive treatment for refractory MDD.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03610048
Study type Interventional
Source Alkermes, Inc.
Status Enrolling by invitation
Phase Phase 3
Start date August 9, 2018
Completion date July 2021